Research ArticleLaboratory Studies
Improved Targeting of Radiolabeled Streptavidin in Tumors Pretargeted with Biotinylated Monoclonal Antibodies through an Avidin Chase
Zhengsheng Yao, Meili Zhang, Hisataka Kobayashi, Harumi Sakahara, Hiroshi Nakada, Ikuo Yamashina and Junji Konishi
Journal of Nuclear Medicine May 1995, 36 (5) 837-841;
Zhengsheng Yao
Meili Zhang
Hisataka Kobayashi
Harumi Sakahara
Hiroshi Nakada
Ikuo Yamashina
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Improved Targeting of Radiolabeled Streptavidin in Tumors Pretargeted with Biotinylated Monoclonal Antibodies through an Avidin Chase
Zhengsheng Yao, Meili Zhang, Hisataka Kobayashi, Harumi Sakahara, Hiroshi Nakada, Ikuo Yamashina, Junji Konishi
Journal of Nuclear Medicine May 1995, 36 (5) 837-841;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Pfcerli2, a duplicated gene in the malaria parasite Plasmodium falciparum essential for invasion of erythrocytes as revealed by phylogenetic and cell biological analysis
- Evaluation of CD20, CD22, and HLA-DR Targeting for Radioimmunotherapy of B-Cell Lymphomas
- Successful Radiotherapy of Tumor in Pretargeted Mice by 188Re-Radiolabeled Phosphorodiamidate Morpholino Oligomer, a Synthetic DNA Analogue.
- Comparison of a tetravalent single-chain antibody-streptavidin fusion protein and an antibody-streptavidin chemical conjugate for pretargeted anti-CD20 radioimmunotherapy of B-cell lymphomas
- Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy
- Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas
- Pretargeted Radioimmunotherapy of Cancer: Progress Step by Step
- Pretarget radiotherapy with an anti-CD25 antibody-streptavidin fusion protein was effective in therapy of leukemia/lymphoma xenografts
- Pretargeting radioimmunotherapy of a murine model of adult T-cell leukemia with the alpha -emitting radionuclide, bismuth 213
- Development and Characterization of a Series of Soluble Tetrameric and Monomeric Streptavidin Muteins with Differential Biotin Binding Affinities
- Induction of Therapeutic T-Cell Immunity by Tumor Targeting with Soluble Recombinant B7-Immunoglobulin Costimulatory Molecules